The in vitro anti-inflammatory potential of different mushroom extracts was assessed through two methods: the inhibition of xanthine oxidase, involved in uric acid metabolism linked to conditions like gout, and determination of lipoxygenase activity inhibition, associated with the development of allergies and inflammatory processes. This evidence concerns the gene XDH and allergic disease.